Zachary K. Goldsmith et al. 2019. Sirtuin Inhibitor as a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal Melanoma. The Ophthalmology. (Sep. 2019), 21–31.